Malagelada J R, Distrutti E
Digestive System Research Unit, Hospital General Universitari Vall d'Hebron, Autonomous University of Barcelona, Spain.
Drugs. 1996 Oct;52(4):494-506. doi: 10.2165/00003495-199652040-00003.
The focus of management of gastrointestinal motility disorders should be to improve survival and quality of life. Some motor disorders are annoying, but are compatible with virtually normal activity and carry no significant life risk. Conversely, other motor disorders are highly incapacitating and may shorten life expectancy because of complications and nutritional impairment. Management is based first on establishing the correct diagnosis and prognosis; secondly, on adjusting therapy to the severity of illness; and thirdly, on preventing significant complications. Simple recommendations on appropriate changes in lifestyle and reassurance may suffice in mild cases. Pharmacological therapy and, exceptionally, surgical or nutritional measures may be required in other patients. Generally, pharmacological agents should be directed towards correcting specific pathophysiological abnormalities, but this is not always possible. Symptomatic relief may be achieved on an empirical basis. Long term treatment may often require the combination of different therapeutic approaches either sequentially or simultaneously.
胃肠动力障碍的管理重点应是提高生存率和生活质量。一些动力障碍令人烦恼,但实际上与正常活动相容,且不带来重大生命风险。相反,其他动力障碍则极具致残性,可能因并发症和营养损害而缩短预期寿命。管理首先基于确立正确的诊断和预后;其次,根据疾病严重程度调整治疗;第三,预防重大并发症。对于轻度病例,关于适当改变生活方式的简单建议和安慰可能就足够了。其他患者可能需要药物治疗,极少数情况下需要手术或营养措施。一般来说,药物应针对纠正特定的病理生理异常,但这并非总是可行的。可凭经验实现症状缓解。长期治疗通常可能需要依次或同时结合不同的治疗方法。